Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/14/14 → 5/14/20 |
Funding
- Karyopharm Therapeutics Inc. (Prot #KCP-330-008)
Prot #KCP-330-008: A Randomized, Open Label, Phase 2 Study of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) Versus Specified Physician's Choice in Patients = 60 Years Old with Relapsed/Refractory Acute Myeloid Leukemia (AML) Who are
- Frankfurt, Olga (PD/PI)
Project: Research project